Compass Therapeutics (CMPX) Amortizatization of Intangibles (2021 - 2026)

Compass Therapeutics has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $353000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $353000.0, up 57.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 22.8% YoY), and the FY2025 annual result was $1.2 million, up 2.75% from the prior year.
• Amortizatization of Intangibles came in at $353000.0 for Q1 2026 at Compass Therapeutics, roughly flat from $353000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $353000.0 in Q4 2025 to a low of $219000.0 in Q4 2024.
• The 5-year median for Amortizatization of Intangibles is $295000.0 (2023), against an average of $295647.1.
• Across the five-year window, Amortizatization of Intangibles fell 28.66% in 2024 and soared 61.19% in 2025, its largest moves.
• Compass Therapeutics' Amortizatization of Intangibles stood at $289000.0 in 2022, then gained by 6.23% to $307000.0 in 2023, then dropped by 28.66% to $219000.0 in 2024, then jumped by 61.19% to $353000.0 in 2025, then changed by 0.0% to $353000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $353000.0 (Q1 2026), $353000.0 (Q4 2025), and $352000.0 (Q3 2025), per Business Quant data.